Production of recombinant antigens and antibodies in Nicotiana benthamiana using 'magnifection' technology: GMP-compliant facilities for small- and large-scale manufacturing.

This review describes the adaptation of the plant virus-based transient expression system, magnICON(®) for the at-scale manufacturing of pharmaceutical proteins. The system utilizes so-called "deconstructed" viral vectors that rely on Agrobacterium-mediated systemic delivery into the plant cells for recombinant protein production. The system is also suitable for production of hetero-oligomeric proteins like immunoglobulins. By taking advantage of well established R&D tools for optimizing the expression of protein of interest using this system, product concepts can reach the manufacturing stage in highly competitive time periods. At the manufacturing stage, the system offers many remarkable features including rapid production cycles, high product yield, virtually unlimited scale-up potential, and flexibility for different manufacturing schemes. The magnICON system has been successfully adaptated to very different logistical manufacturing formats: (1) speedy production of multiple small batches of individualized pharmaceuticals proteins (e.g. antigens comprising individualized vaccines to treat NonHodgkin's Lymphoma patients) and (2) large-scale production of other pharmaceutical proteins such as therapeutic antibodies. General descriptions of the prototype GMP-compliant manufacturing processes and facilities for the product formats that are in preclinical and clinical testing are provided.

[1]  G. Lomonossoff,et al.  Extremely High-Level and Rapid Transient Protein Production in Plants without the Use of Viral Replication1 , 2008, Plant Physiology.

[2]  K. Webber,et al.  The regulation of biologic products derived from bioengineered plants. , 2001, Current opinion in biotechnology.

[3]  B. Cornelissen,et al.  Plant-virus-based vectors for gene transfer will be of limited use because of the high error frequency during viral RNA synthesis , 1985, Plant Molecular Biology.

[4]  E. Rybicki.  Plant-produced vaccines: promise and reality. , 2009, Drug discovery today.

[5]  M. Bendandi.  Aiming at a Curative Strategy for Follicular Lymphoma , 2008, CA: a cancer journal for clinicians.

[6]  K. Severinov,et al.  Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase. , 1993, Journal of Biological Chemistry.

[7]  C. Kearney,et al.  Genome evolution of tobacco mosaic virus populations during long-term passaging in a diverse range of hosts , 1999, Archives of Virology.

[8]  Manor Askenazi,et al.  Genome Sequence of the Plant Pathogen and Biotechnology Agent Agrobacterium tumefaciens C58 , 2001, Science.

[9]  S. Marillonnet,et al.  Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  John E. Johnson,et al.  Expression of an animal virus antigenic site on the surface of a plant virus particle. , 1993, Virology.

[11]  B. Hjelm,et al.  An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. , 2008, Vaccine.

[12]  A. V. van Bodegraven,et al.  Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease. , 2009, World journal of gastroenterology.

[13]  K. Ko,et al.  Production of antibodies in plants: approaches and perspectives. , 2009, Current topics in microbiology and immunology.

[14]  R. Reski,et al.  Current achievements in the production of complex biopharmaceuticals with moss bioreactors , 2008, Bioprocess and biosystems engineering.

[15]  K. Whaley,et al.  High‐level rapid production of full‐size monoclonal antibodies in plants by a single‐vector DNA replicon system , 2010, Biotechnology and bioengineering.

[16]  W. Dawson,et al.  Assessment of recombinants that arise from the use of a TMV-based transient expression vector. , 2001, Virology.

[17]  Rainer Fischer,et al.  Plant-based production of biopharmaceuticals. , 2004, Current opinion in plant biology.

[18]  Paul Christou,et al.  Genetic modification: The production of recombinant pharmaceutical proteins in plants , 2003, Nature Reviews Genetics.

[19]  S. Marillonnet,et al.  Viral vectors for the expression of proteins in plants. , 2007, Current opinion in biotechnology.

[20]  W. Dawson,et al.  cDNA cloning of the complete genome of tobacco mosaic virus and production of infectious transcripts. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Marillonnet,et al.  In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Offord,et al.  Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide , 2008, Proceedings of the National Academy of Sciences.

[23]  R. Redfield,et al.  Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults. , 2008, The Journal of infectious diseases.

[24]  S. Garger,et al.  Making an ally from an enemy: plant virology and the new agriculture. , 2002, Annual review of phytopathology.

[25]  N. Talbot,et al.  Plant-Pathogen Interactions , 2007, Methods in Molecular Biology.

[26]  K. Wycoff.  Secretory IgA antibodies from plants. , 2005, Current pharmaceutical design.

[27]  Ernie Hiatt,et al.  Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. , 2010, Plant biotechnology journal.

[28]  Carola Engler,et al.  Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors , 2006, Proceedings of the National Academy of Sciences.

[29]  V. Mett,et al.  Plants as biofactories. , 2008, Biologicals : journal of the International Association of Biological Standardization.

[30]  K. Sugiyama,et al.  Identification of a novel RNA silencing suppressor, NSs protein of Tomato spotted wilt virus , 2002, FEBS letters.

[31]  Louis M Weiner,et al.  Monoclonal antibodies for cancer immunotherapy , 2009, The Lancet.

[32]  C. Borroto,et al.  Large-scale purification of an antibody directed against hepatitis B surface antigen from transgenic tobacco plants. , 2003, Biochemical and biophysical research communications.

[33]  A. Trkola,et al.  Co-receptors for HIV-1 entry. , 1997, Current opinion in immunology.

[34]  D. Longo,et al.  Lymphoma, Non-Hodgkin’s , 2014 .

[35]  G. E. Jones,et al.  Low level of genetic drift in foreign sequences replicating in an RNA virus in plants. , 1993, Virology.

[36]  P. Lerouge,et al.  Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. , 2009, Plant biotechnology journal.

[37]  J. Featherstone,et al.  Clinical Trial of a Plant-Derived Antibody on Recolonization of Mutans Streptococci , 2005, Caries Research.

[38]  J A Eisen,et al.  The Genome of the Natural Genetic Engineer Agrobacterium tumefaciens C58 , 2001, Science.

[39]  S. Marillonnet,et al.  Systemic Agrobacterium tumefaciens–mediated transfection of viral replicons for efficient transient expression in plants , 2005, Nature Biotechnology.

[40]  G. Lomonossoff,et al.  Expression of multiple proteins using full-length and deleted versions of cowpea mosaic virus RNA-2. , 2007, Plant biotechnology journal.

[41]  Richard S Nelson,et al.  A natural variant of a host RNA-dependent RNA polymerase is associated with increased susceptibility to viruses by Nicotiana benthamiana. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Rainer Fischer,et al.  Plant cell cultures for the production of recombinant proteins , 2004, Nature Biotechnology.

[43]  R. Fischer,et al.  Towards molecular farming in the future: transient protein expression in plants , 1999, Biotechnology and applied biochemistry.

[44]  S. Wesselingh,et al.  Production and characterization of an orally immunogenic Plasmodium antigen in plants using a virus-based expression system. , 2009, Plant biotechnology journal.

[45]  J. Carrington,et al.  Silencing on the spot. Induction and suppression of RNA silencing in the Agrobacterium-mediated transient expression system. , 2001, Plant physiology.

[46]  Brian J Ward,et al.  Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. , 2008, Plant biotechnology journal.

[47]  R. Naidu,et al.  Nicotiana benthamiana: its history and future as a model for plant-pathogen interactions. , 2008, Molecular plant-microbe interactions : MPMI.

[48]  D. Baulcombe,et al.  The amplicon-plus system for high-level expression of transgenes in plants , 2002, Nature Biotechnology.

[49]  S. Marillonnet,et al.  Magnifection--a new platform for expressing recombinant vaccines in plants. , 2005, Vaccine.

[50]  A. Trkola,et al.  Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140 , 2001, Journal of Virology.

[51]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[52]  M. Franti,et al.  Potent Antiviral Synergy between Monoclonal Antibody and Small-Molecule CCR5 Inhibitors of Human Immunodeficiency Virus Type 1 , 2006, Antimicrobial Agents and Chemotherapy.

[53]  S. Schillberg,et al.  Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Marillonnet,et al.  High-yield production of authentic human growth hormone using a plant virus-based expression system. , 2005, Plant biotechnology journal.

[55]  L. Vézina,et al.  Transient expression of antibodies in plants using syringe agroinfiltration. , 2009, Methods in molecular biology.

[56]  V. Gomord,et al.  Pharming and transgenic plants. , 2007, Biotechnology annual review.

[57]  J. Howard,et al.  Plant molecular farming: systems and products , 2004, Plant Cell Reports.

[58]  B. Goldman,et al.  Genome Sequence of the Plant Pathogen and Biotechnology Agent Agrobacterium tumefaciens C58 , 2001, Science.

[59]  M. Pauly,et al.  Monoclonal antibodies from plants: A new speed record , 2006, Proceedings of the National Academy of Sciences.

[60]  M. Kumagai,et al.  Transfection of whole plants from wounds inoculated with Agrobacterium tumefaciens containing cDNA of tobacco mosaic virus. , 1993, Journal of virological methods.

[61]  Zhong Huang,et al.  Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. , 2006, Vaccine.

[62]  G. Mack.  FDA balks at Myozyme scale-up , 2008, Nature Biotechnology.

[63]  J. Lindbo.  High-efficiency protein expression in plants from agroinfection-compatible Tobacco mosaic virus expression vectors , 2007, BMC biotechnology.

[64]  S. Marillonnet,et al.  Engineering viral expression vectors for plants: the 'full virus' and the 'deconstructed virus' strategies. , 2004, Current opinion in plant biology.

[65]  W. Dawson,et al.  Systemic expression of a bacterial gene by a tobacco mosaic virus-based vector. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[66]  J. Peters,et al.  A case study for plant-made pharmaceuticals comparing different plant expression and production systems. , 2009, Methods in molecular biology.

[67]  G. Lomonossoff,et al.  Cowpea mosaic virus-based systems for the expression of antigens and antibodies in plants. , 2009, Methods in molecular biology.

[68]  G. Whitelam,et al.  Antibody production in transgenic plants. , 1994, Biochemical Society transactions.

[69]  S. Marillonnet,et al.  Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[70]  J. Lindbo.  TRBO: A High-Efficiency Tobacco Mosaic Virus RNA-Based Overexpression Vector1[C][OA] , 2007, Plant Physiology.

[71]  C. Caranta.  Recent Advances in Plant Virology , 2011 .

[72]  C. Navarre,et al.  Production of antibodies in plants: status after twenty years. , 2010, Plant biotechnology journal.

[73]  D. Baulcombe,et al.  An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus. , 2003, The Plant journal : for cell and molecular biology.

[74]  E. Galun,et al.  A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme—A Preclinical and Phase I Investigation , 2009, PloS one.

[75]  E. Rybicki,et al.  High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector. , 2010, Plant biotechnology journal.